Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-061093

Options or other derivatives

  • Chief Scientific Officer acquired 35,017 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Cundy Kenneth C Chief Scientific Officer 2022-12-09 Grant or award · Stock Option (right to buy) +35,017 35,017 D
Loading xslF345X03/doc4.xml…